Gelteq Limited

US$0.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GELSHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (58.17%)
Div yield —
ROE (42.93%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.36)
PE TTM —
TSR TTM (62.71%)
Mkt cap US$4.921M
ROIC (18.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.428
(2.67%)
(69.79%)
Hold 5|1|5|2|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
9.92%
3.44%
10.73%
(1.96%)
Revenue$M
0.409
0.397
0.414
0.422
5.79%
(1.71%)
4.89%
1.84%
Peers (US$4.921M)
Cap (US$)
PE
5.703M
0.342x
5.345M
148.1x
Capital
TTM
5Y
10Y
Leveragex
0.376
0.352
0.350
EBIT/Intx
1.179
0.219
0.215
Own earn%
(36.35)
(121.78)
(131.50)
Sh yield%
31.75
15.93
17.35
Owners
Insiders/Inst%
10.97
31.89
Short interest%
5.18
SBC / revenue%
3.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
29–34
$1 testx
—
Incr. ROIC%
3